Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,777–3,784 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Sagimet Biosciences Inc. ASC40 (denifanstat) Moderate to severe acne Phase 3 Data Released oral N/A
Sagimet Biosciences Inc. Denifanstat - (FASCINATE-3) Nonalcoholic steatohepatitis (NASH) Phase 2b Data Released Oral Gastroenterology
Sangamo Therapeutics Inc. Civaparvovec (ST-920) - (STAAR) Fabry disease BLA Filing Data Released Intravenous Genetic Disorder
Sangamo Therapeutics Inc. Giroctocogene fitelparvovec (SB-525) - (AFFINE) Hemophilia A BLA Filing Withdrawn Intravenous Hematology
Sanofi Venglustat Tay-Sachs disease / GM-2 gangliosidoses NDA Filing Ongoing Oral Genetic Disorder
Sanofi LIBTAYO (cemiplimab) Cervical cancer NDA Filing Withdrawn intravenous Oncology
Sanofi LIBTAYO (cemiplimab) Cervical cancer NDA Filing Withdrawn intravenous Oncology
Sanofi Venglustat Tay-Sachs disease / GM-2 gangliosidoses NDA Filing Ongoing Oral Genetic Disorder